You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

CLINICAL TRIALS PROFILE FOR RUBOXISTAURIN

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for Ruboxistaurin

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00044395 ↗	Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes	Completed	Eli Lilly and Company	Phase 3	The purpose of this protocol is to determine if an investigational drug is effective in treating nerve malfunction in diabetes.
NCT00044408 ↗	Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes	Completed	Chromaderm, Inc.	Phase 3	The purpose of this protocol is to determine if an investigational drug known as LY333531 is effective in treating nerve malfunction in diabetes.
NCT00044421 ↗	Treatment of Peripheral Neuropathy in Patients With Diabetes	Completed	Eli Lilly and Company	Phase 3	The purpose of this protocol is to determine if an investigational drug is effective in treating nerve malfunction in diabetes.
NCT00090519 ↗	Reduction in the Occurrence of Center-Involved Diabetic Macular Edema	Completed	Chromaderm, Inc.	Phase 3	The purpose of this study is to determine if ruboxistaurin can help slow the worsening of an eye disease called macular edema in patients with diabetes.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Clinical Trial Conditions for Ruboxistaurin

Condition Name

Chart
Table

Condition Name for
Intervention	Trials
Diabetic Retinopathy	3
Diabetes Mellitus	3
Diabetic Neuropathies	3
Diabetes Mellitus, Insulin-Dependent	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for
Intervention	Trials
Diabetes Mellitus	7
Diabetic Neuropathies	4
Diabetes Mellitus, Type 2	4
Diabetes Mellitus, Type 1	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Ruboxistaurin

Trials by Country

Map
Table

Trials by Country for
Location	Trials
United States	111
Canada	19
United Kingdom	16
Spain	8
India	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for
Location	Trials
Massachusetts	6
New York	6
Florida	6
California	6
Texas	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Ruboxistaurin

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for
Clinical Trial Phase	Trials
Phase 3	8
Phase 2/Phase 3	1
Phase 2	3
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for
Clinical Trial Phase	Trials
Completed	12
Recruiting	1
Unknown status	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ruboxistaurin

Sponsor Name

Chart
Table

Sponsor Name for
Sponsor	Trials
Chromaderm, Inc.	9
Eli Lilly and Company	3
Heart and Stroke Foundation of Canada	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for
Sponsor	Trials
Industry	13
Other	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.